Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Original Research
Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,830 | Dovepress* | 15,194+ | 1,653 | 16,847 | |
| PubMed Central* | 2,636 | 743 | 3,379 | ||
| Totals | 17,830 | 2,396 | 20,226 | ||
| *Since 16 April 2018 | |||||
View citations on PubMed Central and Google Scholar